376
Participants
Start Date
July 5, 2006
Primary Completion Date
April 18, 2017
Study Completion Date
May 24, 2018
Retigabine (INN), Ezogabine (USAN)
Film-coated tablets containing 50 mg, 100 mg, or 300 mg of retigabine per tablet. Dosage and frequency will be specific to each patient so long as the patients receives between 600 and 1200 mg of retigabine per day. The duration will be until the completion of the trial, or until the patient withdraws from the trial.
Orszagos Pszichiatriai es Neurologiai Intezet, Budapest
Orszagos Idegsebeszeti Tudomanyos Intezet, Budapest
Centre Neurologique William Lennox, Ottignies
Institute of Clniical Neurosciences, Camperdown
Sunninghill & Kopano Clinical Trials, Johannesburg
Johannesburg Hospital, Johannesburg, Gauteng
Universitaire Ziekenhuizen Gasthuisberg -- Department Neurology, Leuven
Royal Melbourne Hospital, Parkville
Austin & Repatriation Medical Centre, West Heidelberg
Inkosi Albert Luthuli Central Hospital, Durban, KZ-Natal
North Coast Neurology Centre, Maroochydore
Flinders Medical Centre, Bedford Park
Triple M Research, Port Elisabeth, E Cape
Carl Bremer Hospital, Belville, W Cape
Panorama Medi-Clinic, Parow
Groote Schuur Hospital, Cape Town
AZ Sint-Jan, Bruges
Farmovs Parexel, BleomFontein, Free State
Hosp. Virgen de las Nieves, Granada
Hosp. de Donostia Neurology Department, Donostia / San Sebastian
Western Galilee Hospital, Nahariya
Centre Medical de La Teppe, Tain-l'Hermitage
Hospital Ruber Internacional de Madrid, Madrid
Fundacion Jimenez Diaz, Madrid
Kharkov State Medical University, Kharkiv
Institute of Neurology, Psychiatry and Narcology of AMS, Ukr, Kharkiv
Rambam Medical Center, Haifa
CHU Pontchaillou, Rennes
Universitaet Giessen / Marburg Neurologie, Marburg
Hospital de Cruces Neurology Department, Bilbao
Psychosomatic Center of Dnepropetr. Regional Clinic, Dnipro
Hospital Universitario Lozano Blesa Neurology Service, Zaragoza
Chaim Sheba Medical Center, Ramat Gan
Universitaetsklinik Mainz Neurologische Klinik, Mainz
Wolfson Medical Center, Holon
Tel-Aviv Sourasky Medical Center, Tel Aviv
Odessa Regional Clinical Hospital Center for Neurology and Neurosurgery, Odesa
Hopital Neurologique Pierre Wertheimer, Lyon
Assaf Harofeh Medical Center, Beer Yaakov
Kaplan Medical Center, Rehovot
Private Neurologische Paraxis, Muenchen, by
Universitaetslinkum Ulm Poliklinik fuer Neurologie, Ulm, BW
Zentrum Epilepsie Erlangen (ZEE) der Universitaet Erlangen, Erlangen
Hopital Civil de Steasbourg Clinique Neurologie, Levallois-Perret
City Hospital # 1, Moscow
Russian Military Medical Academy, Saint Petersburg
Kazan State Medical University, Kazan'
General Hospital Middelheim -- Department of Neurology, Antwerp
University of Bonn -- Department for Epileptplogy, Bonn
Pecs University of Science, Clinic of Neurology, Pécs
Specjalistyczna Przychodnia Lekarska Medikard, Padlewskiego 4
"Prywatna Wielospecjalistyczna Lecznica Medyczna Zycie", Plac Hallera 5
Oddzial Neurologii -- Klinika Neurologii ICZMP, U1. Parzeczewska 35
"NZOZ Przychodnia Internistyczno - Stomatologiczna Kendron", Bialystok
City Hospital # 33, Moscow
District Antiepileptic Centre City Clinical Hospital # 71, Moscow
Pavlov State Medical University Clinic and Department of Neurology, Saint Petersburg
Wojewodzki Szpital Specjalistyczny im.Mikolaja Kopernika, Gdansk
WSS im.Kardynala S. Wyszynskiego, Lublin
Instytut Psychiatrii i Neurologii II Oddzial Neurologii, Warsaw
Wilgers MR & Medical Centre, Pretoria
Hospital Sta. Creu i S. Pau, Barcelona
Epilepsy Center of Municipal Clinical Psychoneurological Hospital, Kiev
The James Cook University Hospital, Middlesbrough
Fylde Coast Hospital, Blackpool
Western Infirmary (Epilepsy), Glasgow
Royal London Hospital, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY